Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001763494-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | May 7, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
112,500
Total Value
$988,875.00
P&L
+inf% (+$2,014,200.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | May 4, 2026 | Exercise/Conversion | 22,500 | $0.00 | $0.00 | 455,386 | Direct | โ | View Details | |
Director | Common Stock | โ | May 6, 2026 | Sale | 22,500 | $43.95 | $988,875.00 | 432,886 | Direct | โ | View Details | |
Director | Performance-based restricted stock units | Derivative | May 4, 2026 | Grant/Award | 45,000 | $0.00 | $0.00 | 45,000 | Direct | โ | View Details | |
Director | Performance-based restricted stock units | Derivative | May 4, 2026 | Exercise/Conversion | 22,500 | $0.00 | $0.00 | 22,500 | Direct | โ | View Details |